B-Cell Non-Hodgkin Lymphoma — Trials

B-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

6,181 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,757
Recruiting: 905
Ph III recruiting: 103
Growth YoY: +3.6%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (954)

clinicaltrialsPublishedShowing 2,451–2,500 of 2,959 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00931918	Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients	completed	Phase 2	206	Millennium Pharmaceuticals, Inc.INDUSTRY	1	Jan 11, 2017	clinicaltrials
NCT02439138	Study of Phosphatidylinositol-3-kinase (PI3K) Inhibitor Idelalisib (GS-1101) in Waldenström Macroglobulinemia	terminated	Phase 2	5	Dana-Farber Cancer InstituteOTHER	1	Jan 11, 2017